Expertise in
35
conditions

Dr. Rian J. Dickstein

Urology
7580 Buckingham Blvd, Ste 110, 
Hanover, MD 
Accepting New Patients
Offers Telehealth
Expertise in
35
conditions
7580 Buckingham Blvd, Ste 110, 
Hanover, MD 

Overview

Rian Dickstein is a Urologist practicing medicine in Hanover, Maryland.

Dr. Dickstein is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Hydronephrosis, Ureteroscopy, and Nephrectomy.

Dr. Dickstein is board certified in The American Board Of Urology - Urology. He is actively involved in clinical research, co-authoring 28 peer reviewed articles and participating in 6 clinical trials. Dr. Dickstein is currently accepting new patients.

Graduate Institution

Robert Wood Johnson Medical School-Camden (New Jersery)

Residency

Boston University School of Medicine (Massachusetts)

Specialties

Urology

Licenses

Urology in TX

Board Certifications

The American Board Of Urology - Urology

Fellowships

The University of Texas MD Anderson Cancer Center

Hospital Affiliations

Ascension Saint Agnes Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Chesapeake Urology Associates (Hanover)
7580 Buckingham Blvd, Ste 110, Hanover, MD 21076

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer
CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 12, 2026
A Phase 3, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of UGN-102 as Primary Chemoablative Therapy in Patients With Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC) at Intermediate Risk (IR) of Recurrence
A Phase 3, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of UGN-102 as Primary Chemoablative Therapy in Patients With Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC) at Intermediate Risk (IR) of Recurrence
Enrollment Status: Active_not_recruiting
Publish Date: May 11, 2026
Intervention Type: Drug
Study Drug: UGN-102
Study Phase: Phase 3
A Phase 1/2a Pilot Study of Intravesical TSD-001 for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
A Phase 1/2a Pilot Study of Intravesical TSD-001 for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: June 27, 2025
Intervention Type: Drug
Study Drug: Paclitaxel
Study Phase: Phase 1/Phase 2
A Phase 2, Single Arm Study of CG0070 Combined With Pembrolizumab in Patients With Non Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)
A Phase 2, Single Arm Study of CG0070 Combined With Pembrolizumab in Patients With Non Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)
Enrollment Status: Completed
Publish Date: September 25, 2024
Intervention Type: Biological, Other
Study Drugs: Engineered Oncolytic Adenovirus, Pembrolizumab, N-Dodecyl-B-D-Maltoside
Study Phase: Phase 2
A Randomized, Controlled, Open-Label Study of the Efficacy, Durability, and Safety of UGN-102 With or Without TURBT in Patients With Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
A Randomized, Controlled, Open-Label Study of the Efficacy, Durability, and Safety of UGN-102 With or Without TURBT in Patients With Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
Enrollment Status: Terminated
Publish Date: June 06, 2024
Intervention Type: Drug, Procedure
Study Drug: Mitomycin C
Study Phase: Phase 3
A Multicenter, Single-Arm Study Evaluating the Efficacy of Synergo® Radiofrequency-Induced Thermochemotherapy Effect (RITE) With Mitomycin C (Synergo® RITE + MMC) in CIS Non-Muscle Invasive Bladder Cancer (NMIBC) Bacillus Calmette-Guérin (BCG)-Unresponsive Patients With or Without Papillary NMIBC
A Multicenter, Single-Arm Study Evaluating the Efficacy of Synergo® Radiofrequency-Induced Thermochemotherapy Effect (RITE) With Mitomycin C (Synergo® RITE + MMC) in CIS Non-Muscle Invasive Bladder Cancer (NMIBC) Bacillus Calmette-Guérin (BCG)-Unresponsive Patients With or Without Papillary NMIBC
Enrollment Status: Terminated
Publish Date: April 15, 2020
Intervention Type: Combination product
Study Phase: Phase 3
View 5 Less Clinical Trials

28 Total Publications

Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder Cancer.
Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 15, 2025
Similar Doctors
Expertise in
20
conditions
Expertise in
20
conditions
Referral may be required

Johns Hopkins Outpatient Center

601 North Caroline Street, Floor 4, Floor 4, 
Baltimore, MD 
 (9.6 miles away)
410-955-6100
Languages Spoken:
English
See accepted insurances

Arthur Burnett is a Urologist practicing medicine in Baltimore, Maryland. Dr. Burnett is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Priapism, Erectile Dysfunction (ED), Peyronie Disease, Prostatectomy, and Penectomy. Dr. Burnett is board certified in American Board Of Urology.

Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required

Chesapeake Urology Associates (Hanover)

7580 Buckingham Blvd, Ste 110, 
Hanover, MD 
 (16.7 miles away)
410-760-9400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Julio Davalos is a Urologist practicing medicine in Hanover, Maryland. Dr. Davalos is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Kidney Stones, Perirenal Abscess, Carbuncle, Ureteroscopy, and Lithotripsy. Dr. Davalos is board certified in The American Board Of Urology - Urology. Dr. Davalos is currently accepting new patients.

Expertise in
9
conditions
Expertise in
9
conditions
Referral may be required

Brady Urology At The Levi Watkins JR MD Outpatient Center

601 N Caroline St Fl 4, 
Baltimore, MD 
 (9.6 miles away)
410-955-6100
Experience:
10+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mahir Maruf is a Urologist practicing medicine in Baltimore, Maryland. He has been practicing medicine for over 10 years. Dr. Maruf is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Exstrophy of the Bladder, Exstrophy-Epispadias Complex, Cloacal Exstrophy, Bladder Reconstruction, and Osteotomy.

Frequently Asked Questions about Dr. Rian J. Dickstein

How do I make an appointment with Dr. Rian J. Dickstein?

You can book an appointment with Dr. Rian J. Dickstein by calling their office at 410-760-9400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Rian J. Dickstein a top-rated expert for Bladder Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rian J. Dickstein is classified as an Elite expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Rian J. Dickstein specialize in?

While Dr. Rian J. Dickstein is a Urology, they have specific expertise in Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Hydronephrosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.

Does Dr. Rian J. Dickstein participate in research or clinical trials?

Yes. Dr. Rian J. Dickstein has published 28 articles and abstracts on conditions like Bladder Cancer. You can view a list of Dr. Rian J. Dickstein's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Rian J. Dickstein accept my insurance?

Dr. Rian J. Dickstein accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-760-9400 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dickstein's expertise for a condition
ConditionClose
View All 13 Distinguished Conditions
View All 20 Advanced Conditions
View All 27 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile